Purchase Order FA442721P0033
Award Date 3/5/21
Potential Completion Date 5/4/21
Potential Value $110K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Travis AFB, Fairfield, CA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a $131,500.00 firm fixed-price purchase order to Bausch Health US LLC, a global pharmaceutical and medical device company, for the supply of the VASERLIP O 2.2 SYSTEM. The contract has a completion date of July 20, 2023 and was awarded on June 15, 2023. Bausch Health US LLC is a for-profit limited liability company that has received multiple federal contract awards from the VA and Department of Defense to...
- <p>The Department of Veterans Affairs Veterans Health Administration awarded a Firm Fixed Price purchase order to Valeant Pharmaceuticals International Corporation, Division: Valeant Pharmaceuticals North America, for the provision of a LIPOSUCTION SYSTEM. The contract, which does not have a set-aside designation, was awarded on June 21, 2017 with a completion date of July 20, 2017 and a potential value of $148,400.00. The place of performance is Loma Linda, CA 92357, USA.</p>
- <p>This is a firm fixed-price purchase order awarded by the Defense Health Agency, a defense agency, to Valeant Pharmaceuticals International Corporation for the procurement of a VHP VASER HANDPIECE. The contract has a ceiling value of $22,510.50 and a completion date of September 23, 2016. The contract was not set aside for any specific business type. As a manufacturer of goods, Valeant Pharmaceuticals International Corporation is the prime contractor for this award.</p>
- The federal contract award in question was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,328.52, is for the delivery of 200-unit vials of Botox. It is a Firm Fixed Price Delivery Order contract with a completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, with an identified value of $27,942.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds significant Indefinite Delivery Contracts with DLA and the Department of Justice Federal Bureau of Investigation. The contract is for the delivery of 200 unit vials of the drug Botox, a common treatment for various medical conditions. The contract has a firm fixed price with a completion date...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,045.00 firm fixed price delivery order is for the procurement of 200 unit vials of Botox, a specialty pharmaceutical product. The contract has an ultimate completion date of December 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $1,722.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 100 unit vials, with a completion date of February 6, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,011.25 firm fixed-price delivery order is for the supply of 200-unit vials of Botox, a pharmaceutical medication. The contract has a ceiling value of $3,011.25 and an ultimate completion date of December 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
- The Defense Logistics Agency awarded a $10,257.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on June 27, 2025, with completion targeted for July 21, 2025. This non-competitive award, issued from the company's Conshohocken, Pennsylvania location, represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award reflects routine medical procurement for federal healthcare systems, leveraging the...
- This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...